{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:41:56Z","timestamp":1769600516129,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Dept. of Health and Science","award":["ABT08-65990\/2014-4"],"award-info":[{"award-number":["ABT08-65990\/2014-4"]}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ijantimicag.2017.02.024","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T18:46:43Z","timestamp":1495046803000},"page":"272-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Low penetration of caspofungin into cerebrospinal fluid following intravenous administration of standard doses"],"prefix":"10.1016","volume":"50","author":[{"given":"Volker","family":"Strenger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fedja","family":"Farowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J\u00fcrgen","family":"Dornbusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Sperl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herwig","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Benesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Urban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2141.2005.05749.x","article-title":"Management of intracranial fungal infections in patients with haematological malignancies","volume":"131","author":"Mattiuzzi","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0020","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0025","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1093\/jac\/dku148","article-title":"Amphotericin B transfer to CSF following intravenous administration of liposomal amphotericin B","volume":"69","author":"Strenger","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijantimicag.2014.08.012","article-title":"Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies","volume":"45","author":"Raad","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0035","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","article-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation","volume":"15","author":"Groll","year":"2014","journal-title":"Lancet Oncol"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2017.02.024_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12569","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000331860","article-title":"Efficacy and safety of current drug therapies for invasive aspergillosis","volume":"88","author":"Traunmuller","year":"2011","journal-title":"Pharmacology"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ijantimicag.2016.02.004","article-title":"Pharmacokinetic\/pharmacodynamic adequacy of echinocandins against Candida spp. in intensive care unit patients and general patient populations","volume":"47","author":"Yang","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0055","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ijantimicag.2015.08.009","article-title":"Assessment of echinocandin regimens by pharmacokinetic\/pharmacodynamic analysis against Candida spp. in paediatric patients","volume":"46","author":"Xu","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0060","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/jac\/dkh306","article-title":"Treatment of meningeal coccidioidomycosis with caspofungin","volume":"54","author":"Hsue","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0065","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/AAC.02719-14","article-title":"Very-high-dose caspofungin combined with voriconazole to treat central nervous system aspergillosis: substantial penetration of caspofungin into cerebrospinal fluid","volume":"58","author":"Reminiac","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0070","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/jac\/dkg230","article-title":"Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans","volume":"51","author":"Hossain","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0075","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/AAC.46.8.2564-2568.2002","article-title":"Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis","volume":"46","author":"Kirkpatrick","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0080","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1128\/AAC.01276-09","article-title":"Quantitation of azoles and echinocandins in compartments of peripheral blood by liquid chromatography\u2013tandem mass spectrometry","volume":"54","author":"Farowski","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0085","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/JCM.44.3.760-763.2006","article-title":"In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0090","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.01730-10","article-title":"Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)","volume":"55","author":"Espinel-Ingroff","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0095","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1128\/AAC.41.11.2339","article-title":"Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)","volume":"41","author":"Hajdu","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0100","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1128\/AAC.48.3.815-823.2004","article-title":"Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma","volume":"48","author":"Stone","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0105","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood\u2013cerebrospinal fluid\/blood\u2013brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2017.02.024_bib0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1099\/jmm.0.46549-0","article-title":"Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1\u21923)-\u03b2-d-glucan in clinical specimens","volume":"56","author":"Khan","year":"2007","journal-title":"J Med Microbiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917301590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917301590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T19:44:03Z","timestamp":1569354243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917301590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0924857917301590"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.02.024","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low penetration of caspofungin into cerebrospinal fluid following intravenous administration of standard doses","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}